Relación entre el microbioma vaginal y las infecciones vaginales recurrentes: factores de riesgo y enfoques terapéuticos emergentes
Keywords:
Vaginal microbiome, Recurrent infections, Lactobacilli, Emerging therapies, Prevention.Abstract
The vaginal microbiome plays a crucial role in gynecological health, influencing the incidence and management of recurrent vaginal infections. These infections, often caused by microbial imbalances, significantly affect women's quality of life. Recent studies suggest that a healthy vaginal microbiome, characterized by the predominance of lactobacilli, provides protection against pathogens such as Candida albicans and Gardnerella vaginalis. However, factors such as antibiotic use, excessive hygiene, and hormonal fluctuations can disrupt this balance, promoting the growth of pathogenic bacteria and recurrence of infections. In this context, emerging therapeutic approaches, such as the use of probiotics and microbiome modulation, show promise in preventing and treating these infections. This study explores the relationship between the vaginal microbiome and recurrent infections, highlighting the latest and most effective therapeutic interventions.Downloads
References
1. Chen X, Lu Y, Chen T, Li R. The Female Vaginal Microbiome in Health and Bacterial Vaginosis. Front Cell Infect Microbiol. 2021 [citado 09/08/2023];11:631972. Disponible en:
https://pmc.ncbi.nlm.nih.gov/articles/PMC8058480/
2.Pekmezovic M, Mogavero S, Naglik JR, Hube B. Host–Pathogen Interactions during Female Genital Tract Infections. Trends Microbiol. 2019 [citado 06/08/2024];27(12):982-996. Disponible en: https://www.cell.com/trends/microbiology/abstract/S0966-842X(19)30190-8?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0966842X19301908%3Fshowall%3Dtrue
3.Peebles K, Velloza J, Balkus JE, McClelland RS, Barnabas RV. High Global Burden and Costs of Bacterial Vaginosis: A Systematic Review and Meta-Analysis. Sex Transm Dis. 2019 [citado 09/05/2023];46(5):304-311. Disponible en:
4.Tuddenham S, Gajer P, Burke AE, Murphy C, Klein SL, Stennett CA, et al. Lactobacillus-dominance and rapid stabilization of vaginal microbiota in combined oral contraceptive pill users examined through a longitudinal cohort study with frequent vaginal sampling over two years. EBioMedicine. 2023 [citado 09/05/2023];87:104407. Disponible en:
https://pmc.ncbi.nlm.nih.gov/articles/PMC9792759/
5.Holdcroft AM, Ireland DJ, Payne MS. The Vaginal Microbiome in Health and Disease—What Role Do Common Intimate Hygiene Practices Play? Microorganisms. 2023 [citado 03/05/2024];11(2):298. Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC9959050/
6. Hills RD, Pontefract BA, Mishcon HR, Black C, Sutton SC, Theberge CR. Gut Microbiome: Profound Implications for Diet and Disease. Nutrients. 2019 [citado 06/08/2024];11(7):1613. Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC6682904/
7.Superti F, De Seta F. Warding Off Recurrent Yeast and Bacterial Vaginal Infections: Lactoferrin and Lactobacilli. Microorganisms. 2020 [citado 09/06/2023];8(1):130. Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC7023241/
8. Kalia N, Singh J, Kaur M. Immunopathology of Recurrent Vulvovaginal Infections: New Aspects and Research Directions. Front Immunol. 2019 [citado 09/06/2024];10:2034. Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC6722227/
9. Donders G, Sziller IO, Paavonen J, Hay P, de Seta F, Bohbot JM, et al. Management of recurrent vulvovaginal candidosis: Narrative review of the literature and European expert panel opinion. Front Cell Infect Microbiol. 2022 [citado 03/08/2024];12:934353. Dispinible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC9504472/
10.Lehtoranta L, Ala-Jaakkola R, Laitila A, Maukonen J. Healthy Vaginal Microbiota and Influence of Probiotics Across the Female Life Span. Front Microbiol. 2022 [citado 05/07/2023];13:819958. Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC9024219/
11.Dekaboruah E, Suryavanshi MV, Chettri D, Verma AK. Human microbiome: an academic update on human body site specific surveillance and its possible role. Arch Microbiol. 2020 [citado 08/06/2023];202(8):2147-2167. Disponible en:
https://pmc.ncbi.nlm.nih.gov/articles/PMC7284171/
12.Chen X, Lu Y, Chen T, Li R. The Female Vaginal Microbiome in Health and Bacterial Vaginosis. Front Cell Infect Microbiol. 2021 [citado 08/06/2023];11:631972. Disponible en:
https://pmc.ncbi.nlm.nih.gov/articles/PMC8058480/
13.Moosa Y, Kwon D, de Oliveira T, Wong EB. Determinants of Vaginal Microbiota Composition. Front Cell Infect Microbiol. 2020 [citado 08/06/2023];10:467. Disponible en:
https://pmc.ncbi.nlm.nih.gov/articles/PMC7492712/
14.Baud A, Hillion KH, Plainvert C, Tessier V, Tazi A, Mandelbrot L, et al. Microbial diversity in the vaginal microbiota and its link to pregnancy outcomes. Sci Rep. 2023 [citado 08/06/2023];13(1):9061. Disponible en:
https://pmc.ncbi.nlm.nih.gov/articles/PMC10239749/
15.Abou Chacra L, Fenollar F. Exploring the global vaginal microbiome and its impact on human health. Microb Pathog. 2021 [citado 08/06/2023];160:105172. Disponible en:
https://www.sciencedirect.com/science/article/abs/pii/S0882401021004460?via%3Dihub
16. Khryanin AA, Knorring GY.Vaginal microbiome and the role of probiotics in maintaining women’s health. Pharmateca. 2024 [citado 08/12/2024];31(5): Disponible en:
https://journals.eco-vector.com/2073-4034/article/view/637421
17.Ahmed M, Admassu D, Abate D. Bacterial Vaginosis and Associated Factors Among Pregnant Women Attending Antenatal Care in Harar City, Eastern Ethiopia. Infect Drug Resist. 2022 [citado 08/06/2023];15:3077-3086. Disponible en:
https://pmc.ncbi.nlm.nih.gov/articles/PMC9215287/
18.Dubé‐Zinatelli E, Cappelletti L, Ismail N. Vaginal Microbiome: Environmental, Biological, and Racial Influences on Gynecological Health Across the Lifespan. Am J Reprod Immunol. 2024 [citado 08/06/2023];92(6):e70026. Disponible en:
https://pmc.ncbi.nlm.nih.gov/articles/PMC11640209/
19.Han Y, Liu Z, Chen T. Role of Vaginal Microbiota Dysbiosis in Gynecological Diseases and the Potential Interventions. Front Microbiol. 2021 [citado 08/06/2023];12:643422. Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC8249587/
20. Vodstrcil LA, Muzny CA, Plummer EL, Sobel JD, Bradshaw CS. Bacterial vaginosis: drivers of recurrence and challenges and opportunities in partner treatment. BMC Med. 2021 [citado 08/06/2023];19(1):194. Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC8411528/
21. Zhang F, Zhang T, Ma Y, Huang Z, He Y, Pan H, et al. Alteration of vaginal microbiota in patients with unexplained recurrent miscarriage. Exp Ther Med. 2019 [citado 10/04/2023];17(4):3307-3316. Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC6447762/
22. Rosati D, Bruno M, Jaeger M, Ten Oever J, Netea MG. Recurrent Vulvovaginal Candidiasis: An Immunological Perspective. Microorganisms. 2020 [citado 08/06/2023];8(2):144. Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC7074770/
23.Van Ende M, Wijnants S, Van Dijck P. Sugar Sensing and Signaling in Candida albicans and Candida glabrata. Front Microbiol. 2019 [citado 08/06/2023];10:99. Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC6363656/
24. Guinan J, Wang S, Hazbun TR, Yadav H, Thangamani S. Antibiotic-induced decreases in the levels of microbial-derived short-chain fatty acids correlate with increased gastrointestinal colonization of Candida albicans. Sci Rep. 2019 [citado 02/08/2023];9(1):8872. Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC6586901/
25.Ceccarani C, Foschi C, Parolin C, D’Antuono A, Gaspari V, Consolandi C, et al. Diversity of vaginal microbiome and metabolome during genital infections. Sci Rep. 2019 [citado 08/06/2023];9(1):14095. Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC6773718/
26.Jang SJ, Lee K, Kwon B, You HJ, Ko G. Vaginal lactobacilli inhibit growth and hyphae formation of Candida albicans. Sci Rep. 2019 [citado 08/06/2023];9(1):8121. Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC6544633/
27. Borghi M, Pariano M, Solito V, Puccetti M, Bellet MM, Stincardini C, et al. Targeting the Aryl Hydrocarbon Receptor With Indole-3-Aldehyde Protects From Vulvovaginal Candidiasis via the IL-22-IL-18 Cross-Talk. Front Immunol. 2019 [citado 08/06/2023];10:2364. Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC6798081/
28.Margarita V, Fiori PL, Rappelli P. Impact of Symbiosis Between Trichomonas vaginalis and Mycoplasma hominis on Vaginal Dysbiosis: A Mini Review. Front Cell Infect Microbiol. 2020 [citado 08/06/2023];10:179. Disponible en:
https://pmc.ncbi.nlm.nih.gov/articles/PMC7226223/
29.Margarita V, Marongiu A, Diaz N, Dessì D, Fiori PL, Rappelli P. Prevalence of double-stranded RNA virus in Trichomonas vaginalis isolated in Italy and association with the symbiont Mycoplasma hominis. Parasitol Res.2019 [citado 08/06/2023];118(12):3565-3570. Disponible en: https://link.springer.com/article/10.1007/s00436-019-06469-6
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Micaela Salomé Núñez Carrillo , Sheyla Nicole Armas Robalino , Santiago Sebastián Ortiz Terreros , Sylvia del Pilar Nuñez Arroba
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
ACCESS AND DISTRIBUTION POLICY
All published articles are open access contributions, which are distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided that the primary source of publication is properly cited.
